Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

NCT01294462 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

801

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Coronary Syndrome
Percutaneous Coronary Intervention

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel
DRUG: Acetylsalicylic acid ASA

Sponsor

AstraZeneca